press

image

MG Facility Services Awarded $30 Million, Multi-Year Contract With The U.S. Environmental Protection Agency

Sep 15, 2021

MG Facility Services, a Makwa Global company, will provide Multi-Phased Infrastructure Upgrades at the U.S. EPA's Mid-Continent Ecology Division in Duluth, MinnesotaMINNEAPOLIS - Sept. 15, 2021 - PRLog -- MG Facility Services LLC, a SBA 8(a) certified Tribal Enterprise, announced today that it has been awarded the Multi-Phased Infrastructure Upgrades Contract for the U.S. Environmental Protection Agency's (EPA) Mid-Continent Ecology Division in Duluth, Minnesota beginning October 1, 2021 with a total contract value of $30 million.Under this Indefinite-Delivery/Indefinite-Quantity (IDIQ) contract, MG Facility Services will be providing construction and upgrades to the laboratory for the Mid-Continent Ecology Division.   The EPA Mid-Continent Ecology Division's existing main laboratory building is a 93,484 square foot, two story building that was originally constructed in 1967 with a lab addition constructed in 1982, and an administrative addition in 2001."We are proud to have been selected by the EPA to provide these essential upgrades to their Laboratory that have been many years in the making," said CEO Derek Dorr.  "By leveraging local partners we are able to provide the EPA with a customized solution utilizing all local resources."Derek Dorr, a member of the Mille Lacs Band of Ojibwe and former owner of Minnesota-based DECO, Inc., a 20-year seasoned government contractor, said, "Along with a very accomplished and experienced team, we have created a family of companies that specialize in federal government contracting.  The Makwa team has been fortunate, during this COVID challenge, to secure multiple contracts in all five of our federal subsidiaries with MG Facility Services, our construction subsidiary, now having sizable contracts on three continents."About Makwa GlobalMakwa Global, LLC is a Tribal Enterprise (TE) owned by the Mille Lacs Band of Ojibwe, a business-savvy tribe with over 30 companies and 5,000 employees throughout the world. Makwa companies are 8(a) certified and have a diverse set of capabilities, experience, and history ranging from administrative staffing, security, law enforcement and training, facility support, logistics, and advisory/consulting services to governments.ContactStephanie Semanko***@makwaglobal.comPhotos: (Click photo to enlarge) Read Full Story - MG Facility Services Awarded $30 Million, Multi-Year Contract With The U.S. Environmental Protection Agency | More news from this sourcePress release distribution by PRLog

image

Engage2Excel Recruitment Solutions Named a Leader in Recruitment Process Outsourcing (RPO) Services by HRO Today

Sep 15, 2021

MOORESVILLE, N.C. - September 15, 2021 - (Newswire.com) Engage2Excel Recruitment Solutions, part of the Engage2Excel group of companies, has ranked on the 2021 HRO Today's Baker's Dozen List for Midsize Recruitment Process Outsourcing Services (RPO) for the 12th consecutive year. The Baker's Dozen highlights the top RPO providers from hundreds of companies across the country. As the most vast and distinguished customer satisfaction survey in the RPO industry, service providers are ranked on size of deal, as well as breadth and quality of service. "The last year has been extremely volatile, especially for our clients. We've seen a significant reduction in the labor force and then a hiring tsunami as things began to open back up," says Darren Findley, president of Engage2Excel Recruitment Solutions. "This made recruitment and retention more challenging than what it has been in the past. While we had to work even harder to find new creative ways to fill jobs rapidly, our flexibility, nimbleness and ease to contract provided our clients a seamless experience. We are grateful for the outcome of our efforts in making the list again and happy to be a partner for our clients during this challenging time." Engage2Excel Recruitment Solutions' services and its unique, consultative approach to helping clients find and keep talent is validated by the Baker's Dozen recognition. "We work closely with clients on finding the best candidates," says Findley. "We not only find the best talent possible, but also encourage our clients to have a more progressive approach to employee loyalty and retention." HRO Today has shared their rankings of RPO providers, which is found here. About Engage2Excel Group The Engage2Excel group of companies creates engaging career and consumer experiences. Its Career Experience Suite (CXS) provides recruitment, onboarding, employee recognition, manager development and employee survey solutions tailored to each organization and designed to help clients find and keep their talent. With over 3,000 client partners, Engage2Excel has a proud heritage of developing innovative solutions that improve competitive advantage and boost bottom-line results. Learn more at www.engage2excel.com Media Contact: Melissa Meunier | VP of Marketing | 800.688.3024 Press Release Service by Newswire.com Original Source: Engage2Excel Recruitment Solutions Named a Leader in Recruitment Process Outsourcing (RPO) Services by HRO Today

image

Voyageur Pharmaceuticals Ltd., Announces The Creation of a New Scientific Advisory Board With World Class Leading Physicians

Sep 15, 2021

Calgary, Alberta – Voyageur Pharmaceuticals Ltd. (TSX.V: VM) (USA: VYYRF) (the “Company” or “Voyageur”) develops, manufactures and will commercialize high-performance cost effective imaging contrast agents for the medical radiology marketplace. Today the Company announced the formation of its Scientific Advisory Board (SAB) to support the firm’s research, clinical and product development programs. The SAB is to provide Voyageur’s management team, BOD and and imaging consultants Dash International with expert advice and counsel that fulfills the companies mission and vision to provide products that will benefit the healthcare system worldwide. In addition, the SAB will assist with outreach to the medical and scientific community, guide and oversee Voyageur’s innovative programs and bring strategic perspectives to rapidly emerging science and technology trends impacting Voyageur.   The SAB comes together with the following leading imaging physicians and researchers:   Alec J. Megibow, MD   • Professor, Department of Radiology, NYU Grossman School of Medicine   • Professor, Department of Surgery, NYU Grossman School of Medicine   • Director, FPO Outpatient Imaging Services, NYU Langone Health   • Interests: CT and MRI, liver, pancreas, and alimentary tract   C. Daniel Johnson, MD   • Professor of Radiology, Mayo College of Medicine and Science   • Consultant, Department of Radiology, Mayo Clinic, Scottsdale AZ.   • Consultant, Department of Radiology, Mayo Clinic, Rochester, MN   • Adjunct Faculty, College of Health Solutions, Arizona State University.   • Interests: Full structural colorectal screening examination using CT Colonography. Includes exam performance, patient acceptance, cost effectiveness, image display technology, software and CT technology.   Thomas Lauenstein, MD   • Medical Director, Evangelical Hospital, Dusseldorf, Germany   • Interventional Radiology for oncology (SIRT/TACE)   • Interests: Abdominal imaging with a focus on liver, pancreas and bowel. Hybrid imaging (PET/CT) and (PET/MRI)   “We are excited to have such preeminent leaders in their fields joining our SAB” said Brent Willis, CEO of Voyageur Pharmaceuticals Ltd. ”We believe their participation reflects the seriousness of our mission, our strategy and the disruptive promise of our imaging contrast agents. We will benefit from their years of experience and deep expertise as we continue to advance our portfolio of programs and products”.   About Voyageur   Voyageur is a Canadian public company listed on the TSXV under the trading symbol VM. Voyageur is focused on the development of barite and iodine Active Pharmaceutical Ingredients (API) and high-performance cost-effective imaging contrast agents for the medical radiology marketplace. Voyageur’s goal is to initially generate positive cash flow from operations using third party GMP pharmaceutical manufacturers in Canada and internationally. Ultimately, Voyageur has plans to build all the required infrastructure to become 100% self-sufficient with all manufacturing. Voyageur owns a 100% interest in three barium sulfate (barite) projects including the Frances Creek property, suitable in grade for the pharmaceutical barite marketplace, with interests in a high-grade iodine, lithium & bromine brine project located in Utah, USA.   Voyageur is moving forward with its business plan of becoming the only fully integrated company in the radiology medical field, by controlling all primary input costs under the motto of: “From the Earth to the Bottle”.   For Further Media Information or to set up an interview, please contact:   Brent Willis President & CEO E: brent@vpharma.ca   Ron Love CFO T 403.818.6086 E ronl@vpharma.ca   Forward Looking Information   This news release may contain certain forward-looking information and statements, including without limitation, statements pertaining to the preparation and timing of the PEA for Francis Creek, the ability of the upgrading system to process large volumes of barium, the market for the Company’s products, the plant design and costs and the costs for Voyageur to produce natural barium sulfate, the costs to produce man-made barium sulfate, and statements relating to the Company’s long term plans, including with respect to becoming 100% self-sufficient with all manufacturing. All statements included herein, other than statements of historical fact, are forward-looking information and such information involves various risks and uncertainties. There can be no assurance that such information will prove to be accurate, and actual results and future events could differ materially from those anticipated in such information. A description of assumptions used to develop such forward-looking information and a description of risk factors that may cause actual results to differ materially from forward-looking information can be found in the Company’s disclosure documents on the SEDAR website at www.sedar.com. Voyageur does not undertake to update any forward-looking information except in accordance with applicable securities laws.   Reader Advisory   Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this news release.     Media Contact Company Name: Voyageur Pharmaceuticals Ltd Contact Person: Brent Willis Email: Send Email City: Calgary State: Alberta Country: Canada Website: https://voyageurpharmaceuticals.ca/

Items per page:
10
1 – 10 of 326532